Exploration of quantitative-effectiveness association between acupuncture temporal parameters and stable chronic obstructive pulmonary disease: A systematic review and dose-response meta-analysis of randomized controlled trials

IF 4.3 3区 材料科学 Q1 ENGINEERING, ELECTRICAL & ELECTRONIC
Qin Luo , Mingsheng Sun , Guixing Xu , Hao Tian , Chunyan Yang , Liuyang Huang , Xi Li , Ziwen Wang , Guangbing Lu , Zuoqin Yang , Laixi Ji , Fanrong Liang
{"title":"Exploration of quantitative-effectiveness association between acupuncture temporal parameters and stable chronic obstructive pulmonary disease: A systematic review and dose-response meta-analysis of randomized controlled trials","authors":"Qin Luo ,&nbsp;Mingsheng Sun ,&nbsp;Guixing Xu ,&nbsp;Hao Tian ,&nbsp;Chunyan Yang ,&nbsp;Liuyang Huang ,&nbsp;Xi Li ,&nbsp;Ziwen Wang ,&nbsp;Guangbing Lu ,&nbsp;Zuoqin Yang ,&nbsp;Laixi Ji ,&nbsp;Fanrong Liang","doi":"10.1016/j.ctim.2024.103048","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>Chronic Obstructive Pulmonary Disease (COPD) is a globally common chronic respiratory disease with a high morbidity and mortality rate. Acupuncture has been proven effective for COPD. A dose-response meta-analysis was conducted to assess the correlation between the acupuncture temporal parameters(session, frequency, and duration) and its effectiveness in patients with stable COPD.</p></div><div><h3>Methods</h3><p>Acupuncture randomized controlled trials on COPD were searched in eight databases from their inception to June 2023. The \"doses\" were defined as the acupuncture session, frequency, and duration. The outcomes mainly included Forced Expiratory Volume in one-second rate (FEV1%) and Six-minute Walking Distance (6MWD). The assessment of bias risk and literature quality were conducted independently using the Cochrane risk of bias tool and the Standards for reporting interventions in clinical trials of acupuncture. The dose-response relationship was modeled using robust error element regression, and meta-analysis was operated by R 4.3.1 and Stata 15.0. The protocol was registered in PROSPERO with the registration number CRD42023401406.</p></div><div><h3>Result</h3><p>Out of 1669 records, 17 RCTs with 1165 participants were finally included in the meta-analysis. There was notable heterogeneity among the studies, but sensitivity analysis demonstrated good robustness. The findings revealed a significant improvement in the following outcomes for stable COPD patients in the acupuncture group: FEV1% (MD=3.50, 95%CI: 2.05–4.95), 6MWD (MD=47.39, 95%CI: 29.29–65.50), St. George's respiratory questionnaire (SGRQ; MD=−8.25, 95%CI: −11.38 to −5.12); COPD assessment test (CAT; MD=−2.91, 95%CI: −3.99 to −1.83). The relationship between the acupuncture session, duration, and FEV1%, 6MWD followed a \"Λ\" curve pattern, while the relationship between acupuncture frequency and FEV1%, 6MWD exhibited logarithmic growth. Firstly, After 12 acupuncture sessions, FEV1% and 6MWD increased by 7.06% (95%CI: 4.56–9.55) and 36.28 m (95%CI: 20.37–52.20), respectively. The peak improvement in FEV1% and 6MWD was observed after 18 acupuncture sessions (MD=7.89, 95% CI: 5.33–10.45) and 45 sessions (MD=125.43, 95% CI: 72.80–178.07) each. Additionally, weekly acupuncture resulted in a 4.14% improvement in FEV1% (95% CI: 2.55–5.72) and a 42.49 m increase in 6MWD (95%CI: 17.16–67.81). Notably, the maximum effects on FEV1% and 6MWD improvement were achieved with different acupuncture frequencies, specifically three times a week (MD=6.00, 95% CI: 5.34–6.66) and once a day(MD=112.41, 95% CI: 77.27–147.56), respectively. Furthermore, after a 28-day duration of acupuncture treatment, FEV1% increased by 4.74% (95% CI: 3.73–5.75) and 6MWD increased by 47.34 m (95%CI: 22.01–72.67). During 60 days of acupuncture treatment, the FEV1% and 6MWD improvement reached their highest levels at 8.76% (95% CI: 7.05–10.47) and 88.06 m (95% CI: 45.96–130.16), respectively.</p></div><div><h3>Conclusion</h3><p>Acupuncture was effective in improving FEV1%, 6MWD, SGRQ, and CAT in patients with stable COPD. There was a dose-response relationship between the time parameters of acupuncture (session, frequency, and duration) and the efficacy of COPD treatment (FEV1% and 6MWD). The minimal clinically important difference could be achieved after 12 acupuncture sessions. Acupuncture with a medium-frequency (2–3 times per week) over 60 days may result in the greatest improvement in FEV1%, while higher-frequency acupuncture (5–7 times per week) for 2 months may lead to the maximum improvements in 6MWD. It indicated that the optimal acupuncture duration for different indicators remains consistent, while the optimal frequencies may differ. To confirm these results, it is necessary to conduct multicenter, large-scale randomized controlled trials.</p></div><div><h3>Ethics and dissemination</h3><p>Ethical approval is not required for literature-based studies. The results will be published in peer-reviewed journals or conferences.</p></div>","PeriodicalId":3,"journal":{"name":"ACS Applied Electronic Materials","volume":null,"pages":null},"PeriodicalIF":4.3000,"publicationDate":"2024-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0965229924000360/pdfft?md5=580d26e67e88fe32eb28f690bdbf1f26&pid=1-s2.0-S0965229924000360-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Electronic Materials","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0965229924000360","RegionNum":3,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, ELECTRICAL & ELECTRONIC","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a globally common chronic respiratory disease with a high morbidity and mortality rate. Acupuncture has been proven effective for COPD. A dose-response meta-analysis was conducted to assess the correlation between the acupuncture temporal parameters(session, frequency, and duration) and its effectiveness in patients with stable COPD.

Methods

Acupuncture randomized controlled trials on COPD were searched in eight databases from their inception to June 2023. The "doses" were defined as the acupuncture session, frequency, and duration. The outcomes mainly included Forced Expiratory Volume in one-second rate (FEV1%) and Six-minute Walking Distance (6MWD). The assessment of bias risk and literature quality were conducted independently using the Cochrane risk of bias tool and the Standards for reporting interventions in clinical trials of acupuncture. The dose-response relationship was modeled using robust error element regression, and meta-analysis was operated by R 4.3.1 and Stata 15.0. The protocol was registered in PROSPERO with the registration number CRD42023401406.

Result

Out of 1669 records, 17 RCTs with 1165 participants were finally included in the meta-analysis. There was notable heterogeneity among the studies, but sensitivity analysis demonstrated good robustness. The findings revealed a significant improvement in the following outcomes for stable COPD patients in the acupuncture group: FEV1% (MD=3.50, 95%CI: 2.05–4.95), 6MWD (MD=47.39, 95%CI: 29.29–65.50), St. George's respiratory questionnaire (SGRQ; MD=−8.25, 95%CI: −11.38 to −5.12); COPD assessment test (CAT; MD=−2.91, 95%CI: −3.99 to −1.83). The relationship between the acupuncture session, duration, and FEV1%, 6MWD followed a "Λ" curve pattern, while the relationship between acupuncture frequency and FEV1%, 6MWD exhibited logarithmic growth. Firstly, After 12 acupuncture sessions, FEV1% and 6MWD increased by 7.06% (95%CI: 4.56–9.55) and 36.28 m (95%CI: 20.37–52.20), respectively. The peak improvement in FEV1% and 6MWD was observed after 18 acupuncture sessions (MD=7.89, 95% CI: 5.33–10.45) and 45 sessions (MD=125.43, 95% CI: 72.80–178.07) each. Additionally, weekly acupuncture resulted in a 4.14% improvement in FEV1% (95% CI: 2.55–5.72) and a 42.49 m increase in 6MWD (95%CI: 17.16–67.81). Notably, the maximum effects on FEV1% and 6MWD improvement were achieved with different acupuncture frequencies, specifically three times a week (MD=6.00, 95% CI: 5.34–6.66) and once a day(MD=112.41, 95% CI: 77.27–147.56), respectively. Furthermore, after a 28-day duration of acupuncture treatment, FEV1% increased by 4.74% (95% CI: 3.73–5.75) and 6MWD increased by 47.34 m (95%CI: 22.01–72.67). During 60 days of acupuncture treatment, the FEV1% and 6MWD improvement reached their highest levels at 8.76% (95% CI: 7.05–10.47) and 88.06 m (95% CI: 45.96–130.16), respectively.

Conclusion

Acupuncture was effective in improving FEV1%, 6MWD, SGRQ, and CAT in patients with stable COPD. There was a dose-response relationship between the time parameters of acupuncture (session, frequency, and duration) and the efficacy of COPD treatment (FEV1% and 6MWD). The minimal clinically important difference could be achieved after 12 acupuncture sessions. Acupuncture with a medium-frequency (2–3 times per week) over 60 days may result in the greatest improvement in FEV1%, while higher-frequency acupuncture (5–7 times per week) for 2 months may lead to the maximum improvements in 6MWD. It indicated that the optimal acupuncture duration for different indicators remains consistent, while the optimal frequencies may differ. To confirm these results, it is necessary to conduct multicenter, large-scale randomized controlled trials.

Ethics and dissemination

Ethical approval is not required for literature-based studies. The results will be published in peer-reviewed journals or conferences.

针灸时空参数与稳定型慢性阻塞性肺病之间的量效关系探索:随机对照试验的系统回顾和剂量-反应元分析》。
简介慢性阻塞性肺病(COPD)是全球常见的慢性呼吸系统疾病,发病率和死亡率都很高。针灸已被证实对慢性阻塞性肺病有效。为了评估针灸时间参数(疗程、频率和持续时间)与针灸对慢性阻塞性肺病稳定期患者疗效之间的相关性,我们进行了一项剂量-反应荟萃分析:方法:在八个数据库中检索了从开始到 2023 年 6 月期间有关慢性阻塞性肺病的针灸随机对照试验。剂量 "定义为针灸疗程、频率和持续时间。研究结果主要包括一秒钟用力呼气容积(FEV1%)和六分钟步行距离(6MWD)。偏倚风险和文献质量的评估采用 Cochrane 偏倚风险工具和针灸临床试验干预措施报告标准独立进行。剂量-反应关系采用稳健误差元素回归建模,荟萃分析采用 R 4.3.1 和 Stata 15.0。研究方案已在 PROSPERO 注册,注册号为 CRD42023401406:结果:在 1669 条记录中,17 项 RCT 共 1165 名参与者最终被纳入荟萃分析。研究之间存在明显的异质性,但敏感性分析表明其稳健性良好。研究结果显示,针灸组慢性阻塞性肺病稳定期患者的以下疗效有明显改善:FEV1%(MD=3.50,95%CI:2.05-4.95)、6MWD(MD=47.39,95%CI:29.29-65.50)、圣乔治呼吸问卷(SGRQ;MD=-8.25,95%CI:-11.38--5.12);慢性阻塞性肺病评估测试(CAT;MD=-2.91,95%CI:-3.99--1.83)。针灸疗程、持续时间与 FEV1%、6MWD 之间的关系呈 "Λ "型曲线,而针灸次数与 FEV1%、6MWD 之间的关系呈对数增长。首先,针灸 12 次后,FEV1% 和 6MWD 分别增加了 7.06% (95%CI: 4.56-9.55) 和 36.28m (95%CI: 20.37-52.20)。针灸 18 次(MD=7.89,95% CI:5.33-10.45)和 45 次(MD=125.43,95% CI:72.80-178.07)后,FEV1% 和 6MWD 的改善达到峰值。此外,每周针灸可使 FEV1% 提高 4.14%(95%CI:2.55-5.72),6MWD 增加 42.49 米(95%CI:17.16-67.81)。值得注意的是,不同的针灸频率对 FEV1% 和 6MWD 改善的效果最大,具体而言,分别为每周三次(MD=6.00,95% CI:5.34-6.66)和每天一次(MD=112.41,95% CI:77.27-147.56)。此外,针灸治疗 28 天后,FEV1% 增加了 4.74%(95% CI:3.73-5.75),6MWD 增加了 47.34 米(95%CI:22.01-72.67)。针灸治疗 60 天后,FEV1% 和 6MWD 的改善达到最高水平,分别为 8.76% (95% CI: 7.05-10.47) 和 88.06m (95% CI: 45.96-130.16):结论:针灸能有效改善慢性阻塞性肺疾病稳定期患者的 FEV1%、6MWD、SGRQ 和 CAT。针灸的时间参数(疗程、频率和持续时间)与慢性阻塞性肺病的疗效(FEV1%和6MWD)之间存在剂量反应关系。针灸 12 次、疗程 28 天后,可达到最小临床意义差异。中频针灸(每周 2~3 次)持续 60 天可使 FEV1% 改善最大,而高频针灸(每周 5~7 次)持续 2 个月可使 6MWD 改善最大。研究表明,不同指标的最佳针刺时间保持一致,而最佳针刺频率可能有所不同。为了证实这些结果,有必要进行多中心、大规模的随机对照试验:基于文献的研究不需要伦理批准。研究结果将在同行评审期刊或会议上发表。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
7.20
自引率
4.30%
发文量
567
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信